Cardiff Oncology, Inc. (CRDF) stock
CRDFNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.85−0.04 (-4.46%)
Close on Nov 20, 2026Market cap $66.34MP/E –Yield –
Cardiff Oncology total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Cardiff Oncology's total debt was $234.27K at Jun 30, 2020. For fiscal 2019 it was $0. The highest annual figure on record is $16.54M in fiscal 2016.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | -100.0% |
| FY2017 | Dec 31, 2017 | $1.33M | -91.9% |
| FY2016 | Dec 31, 2016 | $16.54M | +0.4% |
| FY2015 | Dec 31, 2015 | $16.47M | +10.2% |
| FY2014 | Dec 31, 2014 | $14.95M | +2768.9% |
| FY2013 | Dec 31, 2013 | $521.16K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2020 | Jun 30, 2020 | $234.27K | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.17M | -92.9% |
| Q4 FY2017 | Dec 31, 2017 | $1.33M | -91.9% |
| Q3 FY2017 | Sep 30, 2017 | $1.49M | -94.0% |
| Q2 FY2017 | Jun 30, 2017 | $1.64M | – |
| Q1 FY2017 | Mar 31, 2017 | $16.57M | – |
| Q4 FY2016 | Dec 31, 2016 | $16.54M | – |
| Q3 FY2016 | Sep 30, 2016 | $24.89M | – |
See a number that looks wrong?